[1] Li F, Zhang Q, Xiao JB, et al. Epidemiology of hand, foot, and mouth disease and genetic characterization of coxsackievirus A16 in Shenyang, Liaoning Province, China, 2013-2023. Viruses, 2024; 16, 1666. doi:  10.3390/v16111666
[2] Zeng HL, Zeng BB, Yi LN, et al. The emergence of coxsackievirus A16 subgenotype B1c: a key driver of the hand, foot, and mouth disease epidemic in Guangdong, China. Viruses, 2025; 17, 219. doi:  10.3390/v17020219
[3] Zhang C, Liu CX, Shi JP, et al. Molecular mechanism of antibody neutralization of coxsackievirus A16. Nat Commun, 2022; 13, 7854. doi:  10.1038/s41467-022-35575-w
[4] Liang ZC, Lin CY, Huo D, et al. First detection of multiple cases related to CV-A16 strain of B1c clade in Beijing in 2022. J Med Virol, 2024; 96, e29796. doi:  10.1002/jmv.29796
[5] Li LF, Li SJ, He WX, et al. Molecular epidemiology of coxsackievirus A16 associated with hand, foot and mouth disease in Fujian province, China from 2020 to 2023. Chin J Exp Clin Virol, 2024; 38, 547−51. (In Chinese)
[6] Han ZZ, Song Y, Xiao JB, et al. Genomic epidemiology of coxsackievirus A16 in mainland of China, 2000-18. Virus Evol, 2020; 6, veaa084.
[7] Yang T, Xie TH, Song X, et al. Sensitivities of five kinds of cells to coxsackievirus A16 and enterovirus 71. Int J Biol, 2015; 38, 161−5. (In Chinese)
[8] Baker RE, Yang WC, Vecchi GA, et al. Increasing intensity of enterovirus outbreaks projected with climate change. Nat Commun, 2024; 15, 6466. doi:  10.1038/s41467-024-50936-3
[9] Xie GC, Li D, Su M, et al. Cell cycle arrest and apoptosis in enterovirus 71-infected human tonsillar epithelial cells UT-SCC-60A. Chin J Control Endemic Dis, 2018; 33, 611−4. (In Chinese)
[10] Alizon S, Hurford A, Mideo N, et al. Virulence evolution and the trade-off hypothesis: history, current state of affairs and the future. J Evol Biol, 2009; 22, 245−59. doi:  10.1111/j.1420-9101.2008.01658.x